Moxyplit CV 625 LB Tablet is a combination of Amoxycillin, Clavulanic Acid, and Lactobacillus, designed to treat bacterial infections while supporting gut health. Amoxycillin is a broad-spectrum antibiotic that works by disrupting bacterial cell wall synthesis, leading to bacterial cell death. Clavulanic Acid is a beta-lactamase inhibitor that protects Amoxycillin from enzymatic breakdown by resistant bacteria, expanding its efficacy against a wider range of bacterial pathogens.
Lactobacillus, a beneficial probiotic, is included in the formulation to help restore and maintain the natural gut flora, which can be disrupted during antibiotic treatment. This helps to minimize the risk of gastrointestinal side effects like diarrhea, a common consequence of antibiotic use.
Moxyplit CV 625 LB Tablet is primarily used to treat infections such as respiratory tract infections (e.g., pneumonia, bronchitis), urinary tract infections, skin and soft tissue infections, and intra-abdominal infections. Its dual action makes it an effective option for patients needing both antibiotic therapy and support for digestive health during treatment.